Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,574 | 454 | 97.6% |
| Consulting Fee | $150.00 | 1 | 1.7% |
| Education | $58.23 | 8 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,117 | 48 | $0 (2022) |
| PFIZER INC. | $819.61 | 47 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $670.01 | 40 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $584.88 | 37 | $0 (2021) |
| Allergan, Inc. | $506.64 | 33 | $0 (2020) |
| AbbVie Inc. | $366.90 | 15 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $347.86 | 27 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $346.46 | 16 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $343.47 | 23 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $317.90 | 22 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $70.90 | 3 | Amgen Inc. ($24.41) |
| 2021 | $944.56 | 54 | Amgen Inc. ($164.79) |
| 2020 | $1,422 | 84 | Janssen Pharmaceuticals, Inc ($369.32) |
| 2019 | $1,248 | 72 | Amgen Inc. ($248.00) |
| 2018 | $2,818 | 137 | Amgen Inc. ($453.54) |
| 2017 | $2,278 | 113 | PFIZER INC. ($315.68) |
All Payment Transactions
463 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/02/2022 | Alfasigma USA, Inc. | — | Food and Beverage | In-kind items and services | $22.11 | General |
| 01/19/2022 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Bone Health | ||||||
| 01/12/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $24.38 | General |
| Category: Cardiovascular | ||||||
| 12/07/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $27.26 | General |
| Category: Cardiovascular | ||||||
| 09/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/07/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Diabetes | ||||||
| 08/26/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $31.43 | General |
| Category: Cardiovascular | ||||||
| 08/26/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.63 | General |
| 08/12/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Bone Health | ||||||
| 08/11/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/05/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Neuroscience | ||||||
| 07/25/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $18.28 | General |
| Category: Neurology | ||||||
| 07/12/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/08/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: RESPIRATORY | ||||||
| 07/06/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 81 | 90 | $33,772 | $6,610 |
| 2021 | 22 | 752 | 992 | $102,669 | $45,866 |
| 2020 | 33 | 1,458 | 2,069 | $88,705 | $58,737 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 50 | $16,726 | $3,162 | 18.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 27 | $12,613 | $1,790 | 14.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $4,434 | $1,657 | 37.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 185 | $32,146 | $15,235 | 47.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 109 | 186 | $19,851 | $10,102 | 50.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 45 | 50 | $19,819 | $5,802 | 29.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 45 | 45 | $9,232 | $5,544 | 60.0% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2021 | 35 | 36 | $10,290 | $2,887 | 28.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 32 | 42 | $2,833 | $1,406 | 49.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 15 | 15 | $1,035 | $978.90 | 94.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 52 | 61 | $995.00 | $644.16 | 64.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 29 | 29 | $715.00 | $474.68 | 66.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 16 | 19 | $1,624 | $462.62 | 28.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 33 | 33 | $675.00 | $431.89 | 64.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 29 | 30 | $470.00 | $291.30 | 62.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 67 | 93 | $442.72 | $272.31 | 61.5% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 13 | 18 | $435.11 | $267.52 | 61.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $564.00 | $261.76 | 46.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 30 | 31 | $372.00 | $240.87 | 64.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 14 | $270.06 | $130.98 | 48.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 29 | 35 | $221.00 | $110.95 | 50.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 12 | 13 | $275.00 | $103.82 | 37.8% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2021 | 12 | 14 | $140.00 | $90.58 | 64.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2021 | 13 | 13 | $138.00 | $75.14 | 54.4% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2021 | 12 | 14 | $126.00 | $53.20 | 42.2% |
About Dr. Elisabeth Jappay, MD
Dr. Elisabeth Jappay, MD is a Internal Medicine healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1538214036.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elisabeth Jappay, MD has received a total of $8,782 in payments from pharmaceutical and medical device companies, with $70.90 received in 2022. These payments were reported across 463 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($8,574).
As a Medicare-enrolled provider, Jappay has provided services to 2,291 Medicare beneficiaries, totaling 3,151 services with total Medicare billing of $111,212. Data is available for 3 years (2020–2022), covering 58 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Salem, OR
- Active Since 01/24/2007
- Last Updated 01/03/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538214036
Products in Payments
- Aimovig (Biological) $526.67
- VRAYLAR (Drug) $375.50
- Livalo (Drug) $346.46
- XARELTO (Drug) $342.69
- INVOKANA (Drug) $327.32
- CHANTIX (Drug) $315.81
- FARXIGA (Drug) $286.41
- Trintellix (Drug) $281.59
- Repatha (Biological) $240.26
- JANUVIA (Drug) $219.72
- NUEDEXTA (Drug) $211.82
- Ozempic (Drug) $190.49
- Prolia (Biological) $185.09
- INJECTAFER (Drug) $182.93
- AJOVY (Drug) $167.50
- TOUJEO (Drug) $166.72
- EVENITY (Biological) $164.72
- SYMBICORT (Drug) $163.21
- ELIQUIS (Drug) $154.14
- JARDIANCE (Drug) $144.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salem
Dr. Michael Katcher, Md, MD
Internal Medicine — Payments: $124,347
Jonh Pineda-Bonilla, Md, MD
Internal Medicine — Payments: $51,042
Dr. Garry Miller, D.o, D.O
Internal Medicine — Payments: $17,070
David Bennion, Md, MD
Internal Medicine — Payments: $13,939
Mr. Gautam Jha, Md, MD
Internal Medicine — Payments: $11,191
Dr. Troy Lunceford, Md, MD
Internal Medicine — Payments: $10,868